SE0103211D0 - New formulations and use thereof - Google Patents
New formulations and use thereofInfo
- Publication number
- SE0103211D0 SE0103211D0 SE0103211A SE0103211A SE0103211D0 SE 0103211 D0 SE0103211 D0 SE 0103211D0 SE 0103211 A SE0103211 A SE 0103211A SE 0103211 A SE0103211 A SE 0103211A SE 0103211 D0 SE0103211 D0 SE 0103211D0
- Authority
- SE
- Sweden
- Prior art keywords
- new formulations
- composition
- nicotine
- therapies
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103211A SE0103211D0 (sv) | 2001-09-27 | 2001-09-27 | New formulations and use thereof |
ES02799530T ES2322847T3 (es) | 2001-09-27 | 2002-09-10 | Formulaciones nuevas y uso de las mismas. |
DK02799530T DK1429769T3 (da) | 2001-09-27 | 2002-09-10 | Nye formuleringer og anvendelse deraf |
AT02799530T ATE420642T1 (de) | 2001-09-27 | 2002-09-10 | Neue formulierungen und ihre verwendung |
CNB028191609A CN100500147C (zh) | 2001-09-27 | 2002-09-10 | 新制剂及其用途 |
EP02799530A EP1429769B1 (en) | 2001-09-27 | 2002-09-10 | New formulations and use thereof |
AU2002334522A AU2002334522B2 (en) | 2001-09-27 | 2002-09-10 | New formulations and use thereof |
MXPA04002854A MXPA04002854A (es) | 2001-09-27 | 2002-09-10 | Nuevas formulaciones y uso de las mismas. |
PCT/SE2002/001611 WO2003026655A1 (en) | 2001-09-27 | 2002-09-10 | New formulations and use thereof |
NZ532527A NZ532527A (en) | 2001-09-27 | 2002-09-10 | Nicotine-containing pharmaceutical composition comprising cocoa powder |
BR0212857-8A BR0212857A (pt) | 2001-09-27 | 2002-09-10 | Formulações e uso destas |
DE60230883T DE60230883D1 (de) | 2001-09-27 | 2002-09-10 | Neue formulierungen und ihre verwendung |
IL16085302A IL160853A0 (en) | 2001-09-27 | 2002-09-10 | Nicotine containing formulations and use thereof |
JP2003530291A JP2005504094A (ja) | 2001-09-27 | 2002-09-10 | 新規の配合物及びその使用 |
CA002461517A CA2461517C (en) | 2001-09-27 | 2002-09-10 | Nicotine formulations comprising cocoa and use thereof |
KR10-2004-7004471A KR20040047866A (ko) | 2001-09-27 | 2002-09-10 | 신규한 제제 및 그의 용도 |
RU2004109153/15A RU2286153C2 (ru) | 2001-09-27 | 2002-09-10 | Новые препараты и их использование |
ARP020103630A AR036640A1 (es) | 2001-09-27 | 2002-09-26 | Formulaciones y uso de las mismas |
ZA2004/02363A ZA200402363B (en) | 2001-09-27 | 2004-03-25 | New formulations and use thereof |
HK05101072.4A HK1068555A1 (en) | 2001-09-27 | 2005-02-08 | New formulations and use thereof |
JP2009238604A JP2010006845A (ja) | 2001-09-27 | 2009-10-15 | 新規の配合物及びその使用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103211A SE0103211D0 (sv) | 2001-09-27 | 2001-09-27 | New formulations and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0103211D0 true SE0103211D0 (sv) | 2001-09-27 |
Family
ID=20285457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0103211A SE0103211D0 (sv) | 2001-09-27 | 2001-09-27 | New formulations and use thereof |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1429769B1 (sv) |
JP (2) | JP2005504094A (sv) |
KR (1) | KR20040047866A (sv) |
CN (1) | CN100500147C (sv) |
AR (1) | AR036640A1 (sv) |
AT (1) | ATE420642T1 (sv) |
AU (1) | AU2002334522B2 (sv) |
BR (1) | BR0212857A (sv) |
CA (1) | CA2461517C (sv) |
DE (1) | DE60230883D1 (sv) |
DK (1) | DK1429769T3 (sv) |
ES (1) | ES2322847T3 (sv) |
HK (1) | HK1068555A1 (sv) |
IL (1) | IL160853A0 (sv) |
MX (1) | MXPA04002854A (sv) |
NZ (1) | NZ532527A (sv) |
RU (1) | RU2286153C2 (sv) |
SE (1) | SE0103211D0 (sv) |
WO (1) | WO2003026655A1 (sv) |
ZA (1) | ZA200402363B (sv) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0103210D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
US7767698B2 (en) | 2002-06-03 | 2010-08-03 | Mcneil Ab | Formulation and use thereof |
SE0300831D0 (sv) * | 2003-03-26 | 2003-03-26 | Pharmacia Ab | New formulations and use therof |
CN104397869B (zh) | 2003-11-07 | 2016-06-08 | 美国无烟烟草有限责任公司 | 烟草组合物 |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
AU2005284908B2 (en) | 2004-09-13 | 2011-12-08 | Morningside Venture Investments Limited | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
GB2468424B (en) * | 2007-04-02 | 2011-11-09 | Parkinson S Inst | Methods and compositions for reduction of side effects of therapeutic treatments |
CN103977003A (zh) | 2007-04-02 | 2014-08-13 | 帕金森氏病研究院 | 用于降低治疗的副作用的方法和组合物 |
MX2009013580A (es) | 2007-06-13 | 2010-01-20 | Otsuka Pharma Co Ltd | Extracto que contiene equol, metodo para la produccion del mismo, metodo para la extraccion de equol, y alimento que contiene equol. |
CN101439053A (zh) * | 2007-11-22 | 2009-05-27 | 何煜 | 一种中药口腔速释制剂及其制造方法 |
WO2009070978A1 (fr) * | 2007-11-22 | 2009-06-11 | Yu He | Libération rapide dans la cavité buccale des produits de santé et procédé de préparation associé |
US9204667B2 (en) * | 2010-12-01 | 2015-12-08 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
WO2013006643A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
CN104338133A (zh) * | 2013-07-24 | 2015-02-11 | 陆媛 | 防治口鼻咽喉上呼吸道感染的嚼服药物组合物及其应用 |
WO2015013679A1 (en) * | 2013-07-26 | 2015-01-29 | Gregory Aharonian | Uses of coca leaf or valerian root to reduce bitterness in foods containing unsweetened cacao |
JP2015084771A (ja) * | 2013-09-24 | 2015-05-07 | アサヒ飲料株式会社 | 容器詰め果汁含有飲料、容器詰め果汁含有飲料の製造方法及び異風味抑制剤 |
WO2016123406A1 (en) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
EP3565617A1 (en) | 2017-01-06 | 2019-11-13 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
CA3096580C (en) * | 2018-04-16 | 2023-05-23 | Poviva Corp. | Compositions infused with nicotine compounds and methods of use thereof |
CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8317576D0 (en) * | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
GB8615676D0 (en) * | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
CA1273878A (en) * | 1987-01-15 | 1990-09-11 | Richard Philip Moody | Nicotine-containing preparation for transdermal administration |
DK615689A (da) * | 1989-11-07 | 1991-05-08 | Anders Dam | Rygesupplement eller rygeerstatningsprodukt |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
FR2717387B1 (fr) * | 1994-03-17 | 1996-10-18 | Hi Pharmtech | Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline. |
SE9803986D0 (sv) * | 1998-11-23 | 1998-11-23 | Pharmacia & Upjohn Ab | New compositions |
SE0103211D0 (sv) * | 2001-09-27 | 2001-09-27 | Pharmacia Ab | New formulations and use thereof |
-
2001
- 2001-09-27 SE SE0103211A patent/SE0103211D0/sv unknown
-
2002
- 2002-09-10 ES ES02799530T patent/ES2322847T3/es not_active Expired - Lifetime
- 2002-09-10 IL IL16085302A patent/IL160853A0/xx unknown
- 2002-09-10 CN CNB028191609A patent/CN100500147C/zh not_active Expired - Fee Related
- 2002-09-10 AU AU2002334522A patent/AU2002334522B2/en not_active Ceased
- 2002-09-10 KR KR10-2004-7004471A patent/KR20040047866A/ko not_active Application Discontinuation
- 2002-09-10 NZ NZ532527A patent/NZ532527A/en not_active IP Right Cessation
- 2002-09-10 DE DE60230883T patent/DE60230883D1/de not_active Expired - Lifetime
- 2002-09-10 MX MXPA04002854A patent/MXPA04002854A/es active IP Right Grant
- 2002-09-10 DK DK02799530T patent/DK1429769T3/da active
- 2002-09-10 EP EP02799530A patent/EP1429769B1/en not_active Expired - Lifetime
- 2002-09-10 WO PCT/SE2002/001611 patent/WO2003026655A1/en active IP Right Grant
- 2002-09-10 CA CA002461517A patent/CA2461517C/en not_active Expired - Fee Related
- 2002-09-10 AT AT02799530T patent/ATE420642T1/de not_active IP Right Cessation
- 2002-09-10 RU RU2004109153/15A patent/RU2286153C2/ru not_active IP Right Cessation
- 2002-09-10 BR BR0212857-8A patent/BR0212857A/pt active Search and Examination
- 2002-09-10 JP JP2003530291A patent/JP2005504094A/ja active Pending
- 2002-09-26 AR ARP020103630A patent/AR036640A1/es unknown
-
2004
- 2004-03-25 ZA ZA2004/02363A patent/ZA200402363B/en unknown
-
2005
- 2005-02-08 HK HK05101072.4A patent/HK1068555A1/xx not_active IP Right Cessation
-
2009
- 2009-10-15 JP JP2009238604A patent/JP2010006845A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE60230883D1 (de) | 2009-03-05 |
BR0212857A (pt) | 2004-10-13 |
HK1068555A1 (en) | 2005-04-29 |
DK1429769T3 (da) | 2009-05-11 |
ES2322847T3 (es) | 2009-06-30 |
CN1561214A (zh) | 2005-01-05 |
JP2010006845A (ja) | 2010-01-14 |
CA2461517A1 (en) | 2003-04-03 |
EP1429769A1 (en) | 2004-06-23 |
ATE420642T1 (de) | 2009-01-15 |
KR20040047866A (ko) | 2004-06-05 |
RU2286153C2 (ru) | 2006-10-27 |
ZA200402363B (en) | 2005-03-30 |
CA2461517C (en) | 2008-09-02 |
CN100500147C (zh) | 2009-06-17 |
WO2003026655A1 (en) | 2003-04-03 |
EP1429769B1 (en) | 2009-01-14 |
IL160853A0 (en) | 2004-08-31 |
AR036640A1 (es) | 2004-09-22 |
NZ532527A (en) | 2005-09-30 |
AU2002334522B2 (en) | 2007-05-24 |
MXPA04002854A (es) | 2005-06-06 |
RU2004109153A (ru) | 2005-04-20 |
JP2005504094A (ja) | 2005-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0103211D0 (sv) | New formulations and use thereof | |
PT1412384E (pt) | Formulação estável de glp-1 modificado | |
TW200505483A (en) | New medicament compositions based on anticholinergically-effective compounds and β-mimetics | |
IL219397A0 (en) | Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same | |
TW200510375A (en) | New compounds | |
MXPA03007837A (es) | Composiciones para suministrar bisfosfonatos. | |
YU37602A (sh) | Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns | |
NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
WO2003084539A3 (en) | New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors | |
MXPA04008068A (es) | Metodo para administrar moleculas de glp-1. | |
DE60202477D1 (de) | Vorrichtung zur verabreichung einer substanz | |
TNSN05046A1 (en) | Method of preparing dry powder inhalation compositions | |
IL164108A (en) | Quinoline derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of medicaments for the treatment of cns and other disorders | |
SE9901875D0 (sv) | Novel compounds | |
HUP0301447A2 (hu) | Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények | |
PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
MXPA04004567A (es) | Compuestos y composiciones de fenoxi amina para adminstrar agentes activos. | |
MXPA03007857A (es) | Compuestos y composiciones para entregar agentes activos. | |
UA90504C2 (ru) | Лекарственное средство для лечения заболеваний дыхательных путей | |
TW200512207A (en) | Substituted 3-(2, 5-disubstituted)pyridyl-4-aryl pyrroles for treating inflammatory diseases | |
SE0200657D0 (sv) | Novel Formulation | |
SE0103210D0 (sv) | New formulations and use thereof | |
ATE353231T1 (de) | Pharmazeutische zusammensetzungen | |
HUP0500958A3 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them | |
MXPA05000978A (es) | Formulaciones farmaceuticas novedosas de comienzo rapido que contienen un compuesto para la disfucion sexual que comprenden polvo de cacao y uso de las mismas. |